We are offering the COVID-19 vaccine to eligible patients based on state and federal guidelines, and as supplies allow. Please do not call us for a vaccine appointment. We are notifying patients individually when they can schedule. so we can notify you. Learn more about the .
Support Dr. Chakravarti's Hirschsprung Disease Study
NYU Langone Health
About My Campaign
Hirschsprung disease (abbreviated as HSCR) is a problem with the way the gut develops and is present from birth. About 1 in 5000 babies is born with HSCR, though this rate varies two-fold across different ethnic groups for reasons still not fully understood.
At NYU Langone Health, Dr. Aravinda Chakravarti's lab studies Hirschsprung disease, and is conducting a large, ongoing genetic study of the disease. To learn more about Dr. Chakravarti's lab and the important work it does, please click here.
Thank you for supporting the lab and its efforts!
This campaign supports: Dr. Chakravarti's Hirschsprung Disease Study
The content or links contained in this page are not products of NYU Langone Health.